Results 101 to 110 of about 1,946,344 (262)

Ebola virus disease: An emerging and re-emerging viral threat.

Journal of Autoimmunity, 2019
The genus Ebolavirus from the family Filoviridae is composed of five species including Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and Ebola virus (previously known as Zaire ebolavirus).
M. Rojas, D. Monsalve, Y. Pacheco, Y. Acosta-Ampudia, C. Ramírez-Santana, A. Ansari, M. Gershwin, J. Anaya   +7 more
semanticscholar   +1 more source

Ebola virus-like particles protect from lethal Ebola virus infection [PDF]

Proceedings of the National Academy of Sciences, 2003
The filovirus Ebola causes hemorrhagic fever with 70–80% human mortality. High case-fatality rates, as well as known aerosol infectivity, make Ebola virus a potential global health threat and possible biological warfare agent. Development of an effective vaccine for use in natural outbreaks, response to biological attack, and protection of
Kelly L, Warfield, Catharine M, Bosio, Brent C, Welcher, Emily M, Deal, Mansour, Mohamadzadeh, Alan, Schmaljohn, M Javad, Aman, Sina, Bavari   +7 more
openaire   +2 more sources

Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease. [PDF]

, 2018
Sexual transmission of Ebola virus (EBOV) has been demonstrated more than a year after recovery from the acute phase of Ebola virus disease (EVD). The mechanisms underlying EBOV persistence and sexual transmission are not currently understood.
Bernbaum, John G., Hagen, Katie R., Holbrook, Michael R., Huzella, Louis M., Jahrling, Peter B., Johnson, Reed F., Perry, Donna L., Schnell, Matthias J.   +7 more
core   +1 more source

The Social and Political Dimensions of the Ebola Response: Global Inequality, Climate Change, and Infectious Disease [PDF]

, 2016
The 2014 Ebola crisis has highlighted public-health vulnerabilities in Liberia, Sierra Leone, and Guinea – countries ravaged by extreme poverty, deforestation and mining-related disruption of livelihoods and ecosystems, and bloody civil wars in the ...
A Kay, A Mabin, A Petherick, AM Saéz, AR Poteete, AT Price-Smith, BA Israel, C Bayntun, D Healy, DA Oladele, E Goffman, E Roe, G Bankoff, G Mitman, GB Cockerham, H Frumkin, I Rashid, J Chippaux, J Moran-Ellis, JC Cohen, JC Dumont, JD Mayer, JE Pinzon, K Lee, KC Seto, M Karamouzian, M Nichter, N Brenner, NL Klenk, P Wald, R Bloch, R Bloch, R Keil, R Keil, R Shields, RE Kasperson, S Baize, S Harman, S Lewis, SH Ali, SM Teutsch, T Olaniyan   +41 more
core   +1 more source

Black Fugitivity in the Sporting Workplace: The Story of Eniola Aluko

Gender, Work &Organization, EarlyView.
ABSTRACT Being a Black fugitive involves constant movement: to find and cultivate spaces of safety and hope. In this paper, I curate a sporting archive about the UK Black women's elite football player Eniola Aluko to read her as a Black fugitive. I demonstrate how she traversed a racist and anti‐Black sporting workplace—where she was unfairly demonized
Aarti Ratna
wiley   +1 more source

Ebola : too far or so close? [PDF]

, 2014
The year 2014 has witnessed the escalation of the largest ever Ebola outbreak which started in Guinea, and later spread to other countries in West Africa.
Pace, David, Torpiano, Paul
core  

Wearable Electronic Monitoring of Vital Signs in Hospitalised Adults: A Nursing Focused Scoping Review of Clinical, Economic and Implementation Outcomes

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To synthesise evidence on wearable devices for continuous vital signs monitoring in adult hospital inpatients, focusing on clinical effectiveness, nursing perspectives, workflow impact, patient experience and resource implications. Design Scoping review.
Sian Myfanwy Shaw, Sophie Bethan Shaw, Gillian Janes   +2 more
wiley   +1 more source

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus

Nature Communications, 2019
There are no approved therapies for Ebola virus infection. Here, to find potential therapeutic targets, we perform a screen for genes essential for Ebola virus (EBOV) infection.
M. Flint, P. Chatterjee, D. L. Lin, L. McMullan, P. Shrivastava-Ranjan, É. Bergeron, Michael K. Lo, S. R. Welch, S. Nichol, Andrew W. Tai, C. Spiropoulou   +10 more
semanticscholar   +1 more source

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

Lancet. Infectious Diseases (Print), 2020
Background The 2013–16 Ebola virus disease epidemic in west Africa caused international alarm due to its rapid and extensive spread resulting in a significant death toll and social unrest within the affected region.
Ruth Thom, T. Tipton, T. Strecker, Y. Hall, Joseph Akoi Boré, P. Maes, Fara Raymond Koundouno, S. K. Fehling, Verena Krähling, K. Steeds, Anitha Varghese, G. Bailey, M. Matheson, Saidou Kouyaté, Moussa 3 Cone, Balla Moussa Keita, S. Kouyaté, Amento Richard Ablam, L. Laenen, V. Vergote, M. Guiver, J. Timothy, B. Atkinson, Lisa J. Ottowell, Kevin S. Richards, A. Bosworth, S. Longet, J. Mellors, D. Pannetier, S. Duraffour, C. Muñoz-Fontela, O. Sow, L. Koivogui, Edmund N. C. Newman, S. Becker, A. Sprecher, H. Raoul, J. Hiscox, A. Henao-Restrepo, Keita Sakoba, N. Magassouba, S. Günther, Mandy Kader Konde, M. Carroll   +43 more
semanticscholar   +1 more source

Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study. [PDF]

, 2016
OBJECTIVES:  To assess the frequency of fatal recrudescence from Ebola virus disease after discharge from treatment centres, and explore the influence of infecting dose on case fatality rates. DESIGN:  Retrospective cohort study.
Bangura, Mohamed S, Bower, Hilary, Checchi, Francesco, Glynn, Judith R, Johnson, Sembia, Kamara, Osman, Oza, Shefali, Smout, Elizabeth, Turay, Cecilia   +8 more
core   +1 more source